Follow The Filings

PRME position history

The shares of Prime Medicine (PRME) that ARK Investment Management LLC reported in each quarter’s 13F.

Equity, COM

Shares held by quarter

New Add Reduce Exit

  1. 2022 Q4: 1,639,984 shares, $30M, 0.26% of portfolio, New
  2. 2023 Q1: 1,922,277 shares, $24M, 0.16% of portfolio, Add +17.2%
  3. 2023 Q2: 2,449,199 shares, $36M, 0.24% of portfolio, Add +27.4%
  4. 2023 Q3: 2,622,429 shares, $25M, 0.19% of portfolio, Add +7.1%
  5. 2023 Q4: 3,138,270 shares, $28M, 0.16% of portfolio, Add +19.7%
  6. 2024 Q1: 5,993,354 shares, $42M, 0.29% of portfolio, Add +91.0%
  7. 2024 Q2: 6,126,773 shares, $31M, 0.28% of portfolio, Add +2.2%
  8. 2024 Q3: 5,660,719 shares, $22M, 0.20% of portfolio, Reduce −7.6%
  9. 2024 Q4: 5,150,233 shares, $15M, 0.13% of portfolio, Reduce −9.0%
  10. 2025 Q1: 3,095,172 shares, $6.2M, 0.06% of portfolio, Reduce −39.9%
  11. 2025 Q2: 2,322,669 shares, $5.7M, 0.04% of portfolio, Reduce −25.0%
  12. 2025 Q3: 5,477,851 shares, $30M, 0.18% of portfolio, Add +135.8%
  13. 2025 Q4: 5,368,526 shares, $19M, 0.12% of portfolio, Reduce −2.0%
  14. 2026 Q1: 6,246,827 shares, $22M, 0.17% of portfolio, Add +16.4%
  15. 2026 Q2: 8,348,746 shares, $31M, 0.20% of portfolio, Add +33.6%
  16. 2026 Q3: 10,043,509 shares, $31M, 0.18% of portfolio, Add +20.3%
Holdings date Value % of holdings Shares Filing date All 13F holders